334 related articles for article (PubMed ID: 27869698)
21. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
22. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting.
Chen H; Chang X; Du D; Liu W; Liu J; Weng T; Yang Y; Xu H; Yang X
J Control Release; 2006 Jan; 110(2):296-306. PubMed ID: 16325954
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy.
Wang Y; Wang S; Shi P
Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388
[TBL] [Abstract][Full Text] [Related]
24. Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies.
Elmowafy M; Shalaby K; Ali HM; Alruwaili NK; Salama A; Ibrahim MF; Akl MA; Ahmed TA
Int J Pharm; 2019 Dec; 572():118781. PubMed ID: 31715347
[TBL] [Abstract][Full Text] [Related]
25. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
Kawadkar J; Pathak A; Kishore R; Chauhan MK
Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
[TBL] [Abstract][Full Text] [Related]
26. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
Shinde UA; Parmar SJ; Easwaran S
Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
[TBL] [Abstract][Full Text] [Related]
27. Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.
Yang Y; Qiu D; Liu Y; Chao L
Drug Des Devel Ther; 2019; 13():3307-3319. PubMed ID: 31571832
[TBL] [Abstract][Full Text] [Related]
28. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
29. [Preparation of podophyllotoxin nanostructured lipid carriers and its effects on immortalized human cervical epithelial cells with HPV infection in vitro].
Chong SB; Zeng K; Li GF; Ren F; Zhu XL; Zhou JJ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1023-8. PubMed ID: 21690061
[TBL] [Abstract][Full Text] [Related]
30. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
31. Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition.
Rapalli VK; Sharma S; Roy A; Singhvi G
Colloids Surf B Biointerfaces; 2021 Oct; 206():111945. PubMed ID: 34216849
[TBL] [Abstract][Full Text] [Related]
32. Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.
Chen Y; Zhou L; Yuan L; Zhang ZH; Liu X; Wu Q
Int J Nanomedicine; 2012; 7():3023-32. PubMed ID: 22787398
[TBL] [Abstract][Full Text] [Related]
33. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
34. Nanostructured lipid carriers for percutaneous administration of alkaloids isolated from Aconitum sinomontanum.
Guo T; Zhang Y; Zhao J; Zhu C; Feng N
J Nanobiotechnology; 2015 Jul; 13():47. PubMed ID: 26156035
[TBL] [Abstract][Full Text] [Related]
35. Nanostructured lipid carriers as vehicles for transdermal iontophoretic drug delivery.
Liu W; Yang X; Zhu Y; Chen H; Xu H
Conf Proc IEEE Eng Med Biol Soc; 2005; 2005():1236-9. PubMed ID: 17282417
[TBL] [Abstract][Full Text] [Related]
36. Topical delivery of enoxaparin using nanostructured lipid carrier.
Jain A; Mehra NK; Nahar M; Jain NK
J Microencapsul; 2013; 30(7):709-15. PubMed ID: 23534492
[TBL] [Abstract][Full Text] [Related]
37. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
Kaur N; Sharma K; Bedi N
Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
[TBL] [Abstract][Full Text] [Related]
38. A Novel Approach for the Development of a Nanostructured Lipid Carrier Formulation by Hot-Melt Extrusion Technology.
Bhagurkar AM; Repka MA; Murthy SN
J Pharm Sci; 2017 Apr; 106(4):1085-1091. PubMed ID: 28040458
[TBL] [Abstract][Full Text] [Related]
39. Nanostructured lipid carrier based topical gel of Ganoderma Triterpenoids for frostbite treatment.
Shen CY; Dai L; Shen BD; Zhou X; Bai JX; Xu H; Lv QY; Han J; Yuan HL
Chin J Nat Med; 2015 Jun; 13(6):454-60. PubMed ID: 26073342
[TBL] [Abstract][Full Text] [Related]
40. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity.
Safwat S; Ishak RAH; Hathout RM; Mortada ND
Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
